Quantcast

AstraZeneca resolves almost all U.S. Seroquel litigation for $647 million (access required)

Published: July 28, 2011

Tags: , , , ,

AstraZeneca Plc has settled almost all lawsuits that claimed its antipsychotic drug Seroquel causes diabetes in some users for a total of $647 million.

Diabetes drug Actos linked to cancer risk (access required)

Published: June 29, 2011

Tags: , , , , ,

The best-selling diabetes medicine may have raised the risk of bladder cancer in patients who took the drug for more than one year, according to the Food and Drug Administration.

Pfizer said to pay $330 million in Prempro settlement (access required)

By: Tony Ogden
Published: February 10, 2011

Tags: , , , ,

Pfizer Inc. agreed to pay about $330 million to resolve claims that its Prempro menopause drug caused breast cancer, in the first large-scale settlements in eight years of litigation, two people familiar with the accords said.

Woman blinded by drug wins $21M in lawsuit (access required)

By: Tony Ogden
Published: September 10, 2010

Tags: , , , ,

A federal jury in New Hampshire has awarded $21 million to a woman blinded and scarred by a prescription drug she took for shoulder pain.

AstraZeneca settles Seroquel suits for $198 million (access required)

By: Allison McAndrew
Published: August 12, 2010

Tags: , ,

Pharmaceutical company AstraZeneca will pay about $198 million to settle over 17,000 lawsuits filed by plaintiffs who developed diabetes after taking the atypical antipsychotic drug Seroquel, used to treat schizophrenia and bipolar disorders.

FDA educates health care providers on misleading ads (access required)

By: Kimberly Atkins
Published: May 16, 2010

Tags: , , ,

WASHINGTON – The Food and Drug Association has launched an initiative aimed at educating health care providers about their role in helping to prevent false and misleading prescription drug advertising.

Sign-up for alerts

NEW FREE WHITE PAPER: E-Discovery

This FREE e-report brought to you by Lawyers USA contains the latest tips for conducting thorough and successful electronic discovery for your trial in 2012. We’ve analyzed the latest court rulings and trends in e-discovery to help you and your clients avoid sanctions and win your case.

Click here to get your free White Paper today!